Merck's response to shortage of hepatitis A vaccines: new batches have entered circulation and supply this month
王俊杰2017
发表于 2024-2-29 16:41:16
263
0
0
On February 29th, regarding the large-scale shortage of imported hepatitis A vaccines in China, MSD China exclusively responded to Interface News that a new batch of MSD hepatitis A vaccines had been issued and entered circulation this month. They will continue to evaluate the production and supply chain of the vaccines and make corresponding business decisions.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Nvidia's "Special Edition" H20 chip for China is available for booking
- Li Zhengqing, Senior Vice President Global and President of Research and Development in China at Merck: Nine valent HPV vaccine adds a second dose vaccination program for women aged 9-14, and Merck "increases efforts" to eliminate cervical cancer
- Merck's imported hepatitis A vaccine has been in widespread shortage in China for more than half a year and has not been approved for issuance
- The "Sky Taxi" is priced at 2.39 million yuan and is now available for sale on Taobao. 12 people have already paid a deposit!
- GlaxoSmithKline: The protection rate of Shingrix vaccine against herpes zoster still reaches 82% after 11 years of injection
- Huang Renxun suddenly! Selling stocks again! There have been over 10 instances of selling stocks
- SINOVAC Sinovac Hepatitis A and Chickenpox Vaccines Approved in Peru
- The 'Apple Tax', which has been significantly reduced in Europe, is still charged at the highest level in China
